Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, ...

Full Year 2024 Results Key Financial Results Revenue: US$92.1m (up 29% from FY 2023).

Stephen Silvestro; President, Chief Executive Officer; OPTIMIZERx Corp. Edward Stelmakh; Chief Financial Officer, Chief Operating Officer; OPTIMIZERx Corp. Andrew D' ...

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and ...

Q4 2024 Results Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsSteve Silvestro - PresidentEdward ...

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up ...

OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of ...

Reports Q4 revenue $32.317M, consensus $30.36M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “I’m incredibly proud of our strong fourth ...

OptimizeRx (NASDAQ:OPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect OptimizeRx to post earnings of $0.25 ...

While OptimizeRx Corporation ( NASDAQ:OPRX ) might not have the largest market cap around , it saw a double-digit ...